Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04382469 |
Recruitment Status :
Completed
First Posted : May 11, 2020
Last Update Posted : May 12, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background: Corona virus disease 2019 (COVID-19) is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Purpose: To give initial experience about COVID-19 in Alexandria-Egypt describing radiological patterns of lung involvement, also surveying prevalence of co-morbid lung diseases and their effect on COVID-19 presentation.
Methods: Retrospective study including 48 patients with positive polymerase chain reaction (PCR) test for COVID-19 during the period from February 2020 till May 2020 in Alexandria/Egypt. Full clinical and laboratory data are obtained. High resolution computed tomography (HRCT) findings are described. Serial follow up studies are done. Surveying co-morbid lung diseases done including tuberculosis (TB), interstitial lung diseases (ILDs), chronic obstructive lung disease (COPD), immune and vascular-related diseases. Prevalence rate is the predominant analysis.
Condition or disease |
---|
COVID |

Study Type : | Observational |
Actual Enrollment : | 48 participants |
Observational Model: | Case-Crossover |
Time Perspective: | Retrospective |
Official Title: | Egyptian Initial Experience About 2019 Novel Corona Virus Disease (COVID-19): Single-center Study Analysis of 48 Patients in Alexandria-Egypt Regarding Radiological Patterns and Co-morbid Lung Diseases |
Actual Study Start Date : | February 1, 2020 |
Actual Primary Completion Date : | April 30, 2020 |
Actual Study Completion Date : | May 1, 2020 |

- Radiological pattern of initial presentation, disease progress, healing and recovery [ Time Frame: "through study completion, an average of 1 month" ]HRCT findings
- Survey of co-morbid lung diseases [ Time Frame: "through study completion, an average of 1 month" ]prevalence

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Positive COVID-19
Exclusion Criteria:
- Incomplete medical records, degrade CT images because of patient tachypnea and motions artifacts, also unremarkable CT scans.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04382469
Egypt | |
Faculty of Medicine, University of Alexandria | |
Alexandria, Egypt, 21526 |
Principal Investigator: | Ahmed Samir, MD | Department of Radio-diagnosis. |
Responsible Party: | Ahmed Samir, Lecturer of radio-diagnosis, Alexandria University |
ClinicalTrials.gov Identifier: | NCT04382469 |
Other Study ID Numbers: |
IRB (00012098), FWA (00018699) |
First Posted: | May 11, 2020 Key Record Dates |
Last Update Posted: | May 12, 2020 |
Last Verified: | May 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | The investigators will recommend further large group future researches for some notices in the study, but preferably not be biased |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Virus Diseases |